Annual long term liabilities:
$11.01B+$361.00M(+3.39%)Summary
- As of today (September 13, 2025), NVS annual total long term liabilities is $11.01 billion, with the most recent change of +$361.00 million (+3.39%) on December 31, 2024.
- During the last 3 years, NVS annual long term liabilities has fallen by -$2.32 billion (-17.40%).
- NVS annual long term liabilities is now -35.59% below its all-time high of $17.10 billion, reached on December 31, 2012.
Performance
NVS Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$6.56B-$80.01M(-1.20%)Summary
- As of today (September 13, 2025), NVS quarterly total long term liabilities is $6.56 billion, with the most recent change of -$80.01 million (-1.20%) on June 30, 2025.
- Over the past year, NVS quarterly long term liabilities has dropped by -$205.01 million (-3.03%).
- NVS quarterly long term liabilities is now -82.73% below its all-time high of $38.01 billion, reached on March 31, 2017.
Performance
NVS quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NVS Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.4% | -3.0% |
| 3 y3 years | -17.4% | -22.6% |
| 5 y5 years | -12.2% | -55.8% |
NVS Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.4% | +3.4% | -44.9% | +0.4% |
| 5 y | 5-year | -24.0% | +3.4% | -56.5% | +0.4% |
| alltime | all time | -35.6% | +308.1% | -82.7% | +13.4% |
NVS Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $6.56B(-1.2%) |
| Mar 2025 | - | $6.64B(-39.7%) |
| Dec 2024 | $11.01B(+3.4%) | $11.01B(+66.7%) |
| Sep 2024 | - | $6.61B(-2.4%) |
| Jun 2024 | - | $6.77B(+3.0%) |
| Mar 2024 | - | $6.57B(-38.3%) |
| Dec 2023 | $10.65B(-10.5%) | $10.65B(+62.9%) |
| Sep 2023 | - | $6.54B(-10.9%) |
| Jun 2023 | - | $7.33B(-3.0%) |
| Mar 2023 | - | $7.57B(-36.5%) |
| Dec 2022 | $11.90B(-10.7%) | $11.90B(+45.7%) |
| Sep 2022 | - | $8.17B(-3.6%) |
| Jun 2022 | - | $8.47B(-9.2%) |
| Mar 2022 | - | $9.33B(-30.0%) |
| Dec 2021 | $13.33B(-8.0%) | $13.33B(+37.8%) |
| Sep 2021 | - | $9.68B(-29.7%) |
| Jun 2021 | - | $13.76B(+1.2%) |
| Mar 2021 | - | $13.60B(-6.1%) |
| Dec 2020 | $14.49B(+15.5%) | $14.49B(-4.1%) |
| Sep 2020 | - | $15.11B(+1.8%) |
| Jun 2020 | - | $14.84B(-3.2%) |
| Mar 2020 | - | $15.34B(+22.3%) |
| Dec 2019 | $12.54B(-15.7%) | $12.54B(-5.8%) |
| Sep 2019 | - | $13.32B(+6.0%) |
| Jun 2019 | - | $12.56B(+8.1%) |
| Mar 2019 | - | $11.62B(-21.9%) |
| Dec 2018 | $14.88B(+20.2%) | $14.88B(+5.9%) |
| Sep 2018 | - | $14.04B(-2.8%) |
| Jun 2018 | - | $14.45B(+12.1%) |
| Mar 2018 | - | $12.89B(+4.2%) |
| Dec 2017 | $12.38B(-19.6%) | $12.38B(-66.8%) |
| Sep 2017 | - | $37.22B(-1.1%) |
| Jun 2017 | - | $37.63B(-1.0%) |
| Mar 2017 | - | $38.01B(+147.0%) |
| Dec 2016 | $15.39B(+4.4%) | $15.39B(-55.2%) |
| Sep 2016 | - | $34.34B(+5.2%) |
| Jun 2016 | - | $32.63B(-0.3%) |
| Mar 2016 | - | $32.74B(+122.0%) |
| Dec 2015 | $14.75B(+4.2%) | $14.75B(-47.3%) |
| Sep 2015 | - | $27.98B(+2.9%) |
| Jun 2015 | - | $27.19B(-7.6%) |
| Mar 2015 | - | $29.44B(+108.0%) |
| Dec 2014 | $14.15B(-2.7%) | $14.15B(-48.2%) |
| Sep 2014 | - | $27.34B(-1.3%) |
| Jun 2014 | - | $27.70B(-8.4%) |
| Mar 2014 | - | $30.24B(+108.0%) |
| Dec 2013 | $14.54B(-15.0%) | $14.54B(-45.4%) |
| Sep 2013 | - | $26.60B(-1.7%) |
| Jun 2013 | - | $27.06B(-1.6%) |
| Mar 2013 | - | $27.49B(+60.8%) |
| Dec 2012 | $17.10B | $17.10B(-46.8%) |
| Sep 2012 | - | $32.16B(+9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $29.33B(+1.7%) |
| Mar 2012 | - | $28.85B(+98.3%) |
| Dec 2011 | $14.55B(-0.1%) | $14.55B(-50.5%) |
| Sep 2011 | - | $29.41B(+0.4%) |
| Jun 2011 | - | $29.29B(-1.3%) |
| Mar 2011 | - | $29.66B(+103.7%) |
| Dec 2010 | $14.56B(+47.1%) | $14.56B(-52.6%) |
| Sep 2010 | - | $30.75B(+32.1%) |
| Jun 2010 | - | $23.28B(+0.6%) |
| Mar 2010 | - | $23.15B(+133.9%) |
| Dec 2009 | $9.90B(+7.8%) | $9.90B(-49.1%) |
| Sep 2009 | - | $19.44B(+6.2%) |
| Jun 2009 | - | $18.30B(+8.3%) |
| Mar 2009 | - | $16.90B(+84.0%) |
| Dec 2008 | $9.18B(+77.5%) | $9.18B(-19.0%) |
| Sep 2008 | - | $11.33B(-6.5%) |
| Jun 2008 | - | $12.11B(+21.2%) |
| Mar 2008 | - | $10.00B(+6.2%) |
| Dec 2007 | $5.17B(-12.7%) | $9.41B(-5.3%) |
| Sep 2007 | - | $9.94B(-9.4%) |
| Jun 2007 | - | $10.98B(+6.9%) |
| Mar 2007 | - | $10.27B(-2.0%) |
| Dec 2006 | $5.92B(+31.0%) | $10.48B(-12.4%) |
| Sep 2006 | - | $11.96B(-0.4%) |
| Jun 2006 | - | $12.01B(+26.3%) |
| Mar 2006 | - | $9.50B(+2.9%) |
| Dec 2005 | $4.52B(-31.6%) | $9.24B(-11.8%) |
| Sep 2005 | - | $10.47B(+4.7%) |
| Jun 2005 | - | $10.01B(+12.9%) |
| Mar 2005 | - | $8.86B(-5.0%) |
| Dec 2004 | $6.60B(+69.5%) | $9.32B(-1.1%) |
| Sep 2004 | - | $9.43B(+0.3%) |
| Jun 2004 | - | $9.40B(-1.3%) |
| Mar 2004 | - | $9.52B(+0.5%) |
| Dec 2003 | $3.90B(-32.5%) | $9.48B(-0.7%) |
| Sep 2003 | - | $9.54B(+1.5%) |
| Jun 2003 | - | $9.40B(+3.2%) |
| Mar 2003 | - | $9.11B(+8.2%) |
| Dec 2002 | $5.77B(+114.0%) | $8.42B(+20.8%) |
| Sep 2002 | - | $6.97B(-0.8%) |
| Jun 2002 | - | $7.02B(+14.0%) |
| Dec 2001 | $2.70B(-40.4%) | $6.16B(+6.4%) |
| Jun 2001 | - | $5.79B(-2.9%) |
| Dec 2000 | $4.53B(-12.0%) | $5.96B(-10.3%) |
| Jun 2000 | - | $6.64B |
| Dec 1999 | $5.14B(+88.6%) | - |
| Dec 1998 | $2.73B(-3.7%) | - |
| Dec 1997 | $2.83B(-52.3%) | - |
| Dec 1996 | $5.94B(+1.4%) | - |
| Dec 1995 | $5.86B(+38.1%) | - |
| Dec 1994 | $4.24B(+12.6%) | - |
| Dec 1993 | $3.77B | - |
FAQ
- What is Novartis AG annual total long term liabilities?
- What is the all time high annual long term liabilities for Novartis AG?
- What is Novartis AG annual long term liabilities year-on-year change?
- What is Novartis AG quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Novartis AG?
- What is Novartis AG quarterly long term liabilities year-on-year change?
What is Novartis AG annual total long term liabilities?
The current annual long term liabilities of NVS is $11.01B
What is the all time high annual long term liabilities for Novartis AG?
Novartis AG all-time high annual total long term liabilities is $17.10B
What is Novartis AG annual long term liabilities year-on-year change?
Over the past year, NVS annual total long term liabilities has changed by +$361.00M (+3.39%)
What is Novartis AG quarterly total long term liabilities?
The current quarterly long term liabilities of NVS is $6.56B
What is the all time high quarterly long term liabilities for Novartis AG?
Novartis AG all-time high quarterly total long term liabilities is $38.01B
What is Novartis AG quarterly long term liabilities year-on-year change?
Over the past year, NVS quarterly total long term liabilities has changed by -$205.01M (-3.03%)